 With the launch of Unlocking Growth Powered by Biotech Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5 CAGR for the 5-year period until 2025, coupled with the ambition to double the companys revenue by 2030. COPENHAGEN, DENMARK 27 September 2021 Unlocking Growth Powered by Biotech is Novozymes strategy towards 2025 based on the solid foundation and successful execution of Better Business with Biology. As part of Unlocking Growth Novozymes is further cementing its position as a Biotech Powerhouse by leveraging and investing in its unique knowledge and position in biological innovation, scale-up, customer interaction, and new high-growth opportunities. 